| Gene symbol | MS4A1 | Synonyms | B1, Bp35, CD20, CVID5, FMC7, LEU-16, S7 | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11q12.2 | dbXrefs | |
| Description | membrane spanning 4-domains A1 | ||||
| GTO ID | GTC2178 |
| Trial ID | NCT04074330 |
| Disease | Non-Hodgkin's Lymphoma |
| Altered gene | CD20 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | TAK-981 |
| Phase | Phase1|Phase2 |
| Recruitment status | Completed |
| Title | A Study of TAK-981 Given With Rituximab in Adults With Relapsed or Refractory CD20-Positive Non-Hodgkin Lymphoma |
| Year | 2019 |
| Country | United States |
| Company sponsor | Takeda |
| Other ID(s) | TAK-981-1501|U1111-1236-0243|2020-003946-36 |
| Cohort 1 | |||||||||
|
|||||||||